Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial

Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial

Abstract Background Ceftriaxone (CTRX) and ampicillin/sulbactam (ABPC/SBT) are recommended by various guidelines as the first-line antibiotics for community-acquired pneumonia (CAP). However, which of these antibiotics is more effective for treating non-aspiration CAP remains unclear. Methods This s...

Full description

Bibliographic Details
Main Authors: Nobuyoshi Hamao, Isao Ito, Satoshi Konishi, Naoya Tanabe, Masahiro Shirata, Issei Oi, Mitsuhiro Tsukino, Hisako Matsumoto, Yoshiro Yasutomo, Seizo Kadowaki, Toyohiro Hirai
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Pulmonary Medicine
Subjects:
Pneumonia
ABPC/SBT
CTRX
Online Access:http://link.springer.com/article/10.1186/s12890-020-01198-4

Internet

http://link.springer.com/article/10.1186/s12890-020-01198-4

Similar Items